University of Vermont Vaccine Testing Center
Welcome,         Profile    Billing    Logout  
 9 Trials 
6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wright, Peter
NCT04529538: Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

Completed
1
226
US
Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin Monovalent Oral Polio Vaccine Type 1 (mOPV1), Sabin Monovalent Oral Polio Vaccine Type 3 (mOPV3), Sabin monovalent oral polio vaccine type 3
PATH, Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention, Viroclinics Biosciences B.V., The Emmes Company, LLC
Poliomyelitis
02/23
02/23
Al-Ibrahim, Mohamed S
NCT05933525: Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model

Active, not recruiting
2
60
US
Travelan, IMM-124E, Placebo, ProMilk 85 milk powder
Immuron Ltd., United States Department of Defense, Naval Medical Research Center
Diarrhea, Travelers Diarrhea, Infectious Diarrhea
04/24
07/24
NCT04768452: A SAD/MAD Study to Evaluate the Safety, Tolerability, PK and PD of MT2004

Recruiting
1
80
US
MT2004, Placebo
Shaanxi Micot Technology Limited Company
Healthy
05/21
08/21
NCT04529538: Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

Completed
1
226
US
Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin Monovalent Oral Polio Vaccine Type 1 (mOPV1), Sabin Monovalent Oral Polio Vaccine Type 3 (mOPV3), Sabin monovalent oral polio vaccine type 3
PATH, Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention, Viroclinics Biosciences B.V., The Emmes Company, LLC
Poliomyelitis
02/23
02/23
Sena, Arlene
NCT04529538: Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

Completed
1
226
US
Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin Monovalent Oral Polio Vaccine Type 1 (mOPV1), Sabin Monovalent Oral Polio Vaccine Type 3 (mOPV3), Sabin monovalent oral polio vaccine type 3
PATH, Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention, Viroclinics Biosciences B.V., The Emmes Company, LLC
Poliomyelitis
02/23
02/23
Crothers, Jessica
NCT04529538: Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

Completed
1
226
US
Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin Monovalent Oral Polio Vaccine Type 1 (mOPV1), Sabin Monovalent Oral Polio Vaccine Type 3 (mOPV3), Sabin monovalent oral polio vaccine type 3
PATH, Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention, Viroclinics Biosciences B.V., The Emmes Company, LLC
Poliomyelitis
02/23
02/23

Download Options